Results 81 to 90 of about 117,196 (345)

COLLAB: A Global Survey of Clinical and Laboratory Assessment in Alopecia Areata by Hair Specialists

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Alopecia areata (AA) is a common non‐scarring alopecia. Data continue to emerge on associations with autoimmune and other conditions. Janus kinase inhibitors (JAKi) are increasingly used to treat AA. Objectives The aim was to assess variation in laboratory testing in patients with AA among hair experts internationally and to compare
Cathal O'Connor, Aoife Boyle, Leila Asfour, Bevin Bhoyrul, Laita Bokhari, George Cotsarelis, Chantal Cotter, Brittany Craiglow, Lara Cutlar, Rachita Dhurat, Ncoza Dlova, Isabella Doche, Jeff Donovan, Aaron M. Drucker, Samantha Eisman, Daniel Fernandes Melo, Matthew J. Harries, Maria Hordinsky, Ahmed Kazmi, Brett King, Antonios Kolios, Nekma Meah, Paradi Mirmirani, Arash Mostaghimi, Manabu Ohyama, Yuliya Ovcharenko, Rodrigo Pirmez, Bianca Maria Piraccini, Lidia Rudnicka, David Saceda‐Corralo, Jerry Shapiro, Cathryn Sibbald, Rod Sinclair, Blake R. C. Smith, Michela Starace, Sergio Vaño‐Galván, Wei Liang Koh, Katherine York, Ian McDonald, Dmitri Wall   +39 more
wiley   +1 more source

Efficacy of Oral Tofacitinib in Alopecia Areata, Alopecia Totalis, and Alopecia Universalis

Cureus
Objectives Tofacitinib, an effective Janus kinase inhibitor (JAKi), has gained increasing interest in recent years for the management of refractory alopecia areata (AA). One of the most prevalent autoimmune diseases is AA, a kind of non-scarring alopecia.
Tirmizi, Syeda Shahmoona, Ahmed, Mahnoor Khalil, Iqbal, Tayyaba, Hashmi, Atif A   +3 more
openaire   +2 more sources

Case Report of a Patient With Psoriasis Vulgaris, Psoriatic Arthritis and Alopecia Universalis Successfully Treated With Tofacitinib and Methotrexate

JEADV Clinical Practice, EarlyView.
We present a case of a 31‐year‐old female with alopecia universalis, psoriasis vulgaris, and psoriatic arthritis, who showed poor response to prior treatments. Following the initiation of a combination therapy with tofacitinib and methotrexate, significant improvements in joint pain and hair regrowth were observed.
Jan Nicolai Wagner, Matthias Augustin, Caroline Gewiss, Carolin Grote, Nesrine Ben‐Anaya   +4 more
wiley   +1 more source

Patterns of insurance coverage for wigs in patients with alopecia areata: a cross-sectional survey

International Journal of Women's Dermatology, 2023
Ogechi Ezemma, BA, Shivali Devjani, MS, Aidan Lee, Kristen J. Kelley, BA, Lisa Anderson, PhD, Nicole Friedland, BA, Maryanne Senna, MD   +6 more
doaj   +1 more source

Psychological Impact of Alopecia Areata

Dermatology research and practice, 2020
Introduction Alopecia areata is one of the commonest causes of nonscarring alopecia. Since hair is a vital part with very high cosmetic concern, hair loss might have a significant negative impact on patient's life.
S. Marahatta, S. Agrawal, Baikuntha Adhikari   +2 more
semanticscholar   +1 more source

COVID-19 vaccination among patients with cicatricial alopecia: patient concerns, experiences, and treatment modifications

International Journal of Women's Dermatology, 2023
Kelly E. Flanagan, MS, James T. Pathoulas, BA, Maryanne M. Senna, MD, Chloe J. Walker, MD, MHS, Isabel Pupo Wiss, BA, Maya Collins, BS, Shaheir Ali, BA, Rita Wanser, MS, Jean Pickford, BS, Wilma Bergfeld, MD   +9 more
doaj   +1 more source

Alopecia resembling an ‘undercut hairstyle’ in a child with acute lymphoblastic leukemia at presentation

Pediatric Hematology Oncology Journal, 2018
Alopecia is unusual at presentation in children with cancer. Alopecia neoplastica has been described in adults with metastatic carcinoma and melanoma. Additionally, alopecia may accompany lymphoma as a paraneoplastic phenomenon.
Sidharth Totadri, Peyam Srinivasan, Deepak Bansal   +2 more
doaj  

Comorbidities of Primary Scarring Alopecias: A Retrospective Multi‐Site Cross‐Sectional Study

JEADV Clinical Practice
Background To date, limited research has compared the systemic comorbidities of primary scarring alopecia types. Such research may provide insight into shared disease mechanisms, elucidate novel pathways for therapeutics, and identify those most at risk ...
Arielle Carolina Mora Hurtado, Sarah Gonzalez, Nicole C. Syder, Arthur Manasyan, Tiana Thompson, Lucy Harvey, Jack Rodman, Nada Elbuluk   +7 more
doaj   +1 more source

A Large Cross-Sectional Survey Study of the Prevalence of Alopecia Areata in the United States

Clinical, Cosmetic and Investigational Dermatology, 2020
Purpose Alopecia areata (AA) is an autoimmune disease characterized by the development of non-scarring alopecia. The prevalence is not well known, and estimates vary considerably with no recent estimates in the United States (US).
M. Benigno, K. Anastassopoulos, A. Mostaghimi, M. Udall, S. Daniel, J. Cappelleri, P. Chander, P. Wahl, J. Lapthorn, L. Kauffman, Linda Chen, E. Peeva   +11 more
semanticscholar   +1 more source

Effect of Natural Polyphenols on Breast Cancer Chemoprevention and Treatment

Molecular Nutrition &Food Research, EarlyView.
Effect of Natural Polyphenols on Breast Cancer proliferation and progression. ABSTRACT Breast cancer is the most common type of malignancy among women worldwide. Significant achievements have been made in diagnostic tools and cancer treatments in the past decade; however, the complexity and heterogeneity of certain breast cancer subtypes often lead to ...
Marzia Sichetti, Martina Giuseffi, Eugenia Giglio, Graziella Marino, Marisabel Mecca   +4 more
wiley   +1 more source